RNS Number : 1534R
Legal & General UCITS ETF PLC
25 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
25/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
136438578.00 |
11.595 |
| L&G UK Equity UCITS ETF |
25/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10925171.86 |
9.104 |
| L&G Global Equity UCITS ETF |
25/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32422987.74 |
11.180 |
| L&G Japan Equity UCITS ETF |
25/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
116314729.38 |
10.493 |
| L&G Europe ex UK Equity UCITS ETF |
25/06/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
99674654.17 |
10.648 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
25/06/2020 |
IE00BFXR5W90 |
4605639 |
USD |
47089654.50 |
10.224 |
| L&G Clean Water UCITS ETF |
25/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15196033.58 |
10.131 |
| L&G Artificial Intelligence UCITS ETF |
25/06/2020 |
IE00BK5BCD43 |
6496000 |
USD |
82187186.83 |
12.652 |
| L&G Healthcare Innovation UCITS ETF |
25/06/2020 |
IE00BK5BC677 |
2650000 |
USD |
32813597.06 |
12.382 |
| L&G Pharma Breakthrough UCITS ETF |
25/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
30122602.43 |
12.049 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
25/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
92632285.70 |
10.069 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
25/06/2020 |
IE00BKLWY790 |
57300000 |
USD |
597794528.34 |
10.433 |
| L&G Battery Value-Chain UCITS ETF |
25/06/2020 |
IE00BF0M2Z96 |
12050000 |
USD |
108733865.28 |
9.024 |
| L&G Ecommerce Logistics UCITS ETF |
25/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
57640677.47 |
10.480 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
25/06/2020 |
IE00BMW3QX54 |
47730616 |
USD |
812845354.12 |
17.030 |
| L&G Cyber Security UCITS ETF |
25/06/2020 |
IE00BYPLS672 |
81536776 |
USD |
1529485177.19 |
18.758 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVKZGZVZKFGGZZ
